diagnost tool
price close busi may
fast-grow compani anim health
diagnost seek take modest us market share
gain expand intern significantli time
solid rais guid buyer
ahead analyst day pt
deliv solid beat top line provid clue major
initi tap first global expans indic intent
work distributor partner outsid unit state think
mark upsid year revenu estim said gener like
stock ahead analyst day especi case expect
come prepar fairli signific new product announc think
may includ new launch urin fecal molecular addit detail
global expans initi tough start year continu
like new product launch also given scarciti valu
thesi anim health small pure-play anim health diagnost continu
believ attract takeout candid particularli anim health
leader zoeti mar inc latter plan merg vet
first corp later acquisit reiter buy rais pt
rais guid call rais baselin revenue target
help beat guid exclud benefit ou
expans major new product line extens invest continu
expect gm growth revenu growth blood diagnost
imag partial off-set ovp
look materi new updat analyst day may nyc expect
provid signific updat analyst day expect least two updat
area includ urin fecal molecular test think could also
learn updat infecti diseas allergi imag coagul data telemedicin
softwar think may see growth target year
us dinner nyc may host privat anim health dinner
nyc investor may ahead analyst day contact us detail
seem ou partner call indic plan
partner exclus us distributor market outsid
north america consist think believ help
meaning expand busi remain seen look supplement
direct sale forc add expect learn detail soon
new revenu sourc new coagul instrument launch
nov roughli contribut imag servic revenu
realiz last year realiz up-front revenu digit imag slatehub
grow salesforc expect american sale forc add
new sale rep start june phase throughout balanc
year coincid new product launch
model rais revenue estim rais
revenue estim rais ep
rais ep estim ep
estim consensu larg expect higher oper expens rel
consensu account new sale forc expans like uptick
spend model gm respect
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
market share gain track line manag expect
indic call track toward goal achiev
veterinari hospit market share growth indic remain earli
meet commit larg custom petvetcar center pet center
expect grow one top ten veterinari healthcar provid unit
state recal heska press releas contract novemb deal
run deal includ in-hous blood diagnost analyz
element dc chemistri analyz element hematolog
analyz element coag analyz spoke manag confid
abil fulfil order throughout balanc
solid deliv rev y/i ahead
street ep beat estim cca rev
y/i beat estim driven imag consum
revenu growth y/i respect ovp revenu
y/i also exceed estim gross margin came
y/i estim due shipment low gm order
larg custom either elanco merck bayer ovp gm came
due time order unfavor mix well plant
util adjust believ ovp gross margin track goal
full year pend posit product mix time order primarili
weight
item watch analyst day includ
earli uptak new slate hub element coag analyz new high-
throughput chemistri analyz element perform tests/hour
offer two-way commun expect time launch reformul
heartworm test pend usda regulatori approv previous indic
expect least two updat urin fecal molecular test
think could also learn updat infecti diseas allergi imag coagul
data telemedicin softwar think may see growth target year
buy unchang target price may
diagnost tool
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
buy unchang target price may
diagnost tool
buy unchang target price may
diagnost tool
